Fortrea Holdings (FTRE) Operating Leases (2022 - 2026)
Fortrea Holdings (FTRE) reported Operating Leases of $55.7 million for Q1 2026, down 5.75% on a YoY basis from $59.1 million in Q1 2025, and up 3.15% quarter-over-quarter from $54.0 million in Q4 2025.
Fortrea Holdings (FTRE) Operating Leases (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Operating Leases for 5 years, with the latest figure at $55.7 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 5.75% year-over-year to $55.7 million; the trailing twelve-month figure through Mar 2026 stood at $55.7 million (down 5.75% YoY), and the FY2025 full-year result was $54.0 million, down 27.03% from the prior year.
- Operating Leases for Q1 2026 stood at $55.7 million, up from $54.0 million in the prior quarter.
- The five-year high for Operating Leases was $80.0 million in Q4 2023, with the low at $51.5 million in Q3 2025.
- Historically, Operating Leases has averaged $61.7 million across 5 years, with a median of $59.5 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Leases climbed 26.18% — and 2025, when it retreated 27.03%.
- Fortrea Holdings' Operating Leases stood at $63.4 million in 2022, then grew by 26.18% to $80.0 million in 2023, then declined by 7.5% to $74.0 million in 2024, then dropped by 27.03% to $54.0 million in 2025, then rose by 3.15% to $55.7 million in 2026.
- The last three Operating Leases figures came in at $55.7 million (Q1 2026), $54.0 million (Q4 2025), and $51.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.70 Mn |
| Dec 31, 2025 | 54.00 Mn |
| Sep 30, 2025 | 51.50 Mn |
| Jun 30, 2025 | 52.90 Mn |
| Mar 31, 2025 | 59.10 Mn |
| Dec 31, 2024 | 74.00 Mn |
| Sep 30, 2024 | 65.40 Mn |
| Jun 30, 2024 | 65.80 Mn |
| Mar 31, 2024 | 59.50 Mn |
| Dec 31, 2023 | 80.00 Mn |
| Sep 30, 2023 | 68.00 Mn |
| Jun 30, 2023 | 52.90 Mn |
| Dec 31, 2022 | 63.40 Mn |